Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today announced the launch of ...
Lantern Pharma Inc. , a clinical-stage, AI-driven precision oncology company, today announced the launch of ZetaOmics, the computational-biology module of its multi-agentic AI co-scientist platform, ...
AI coding benchmark MirrorCode published its full results June 26, showing Claude Opus 4.7 autonomously rebuilt a 60,000-line interpreter and scored 56% overall — completing tasks that take human ...
Dr. Dr. Ahmad Aziz, a scientist at DZNE's Bonn site, has been awarded a „Proof of Concept Grant“ from the European Research Council (ERC). He aims to further develop innovative software for analyzing ...
Vietnam Investment Review on MSN
SCNet AI deploys AI and HPC to put scientific research agents within reach
HONG KONG SAR - Media OutReach Newswire - 25 June 2026 - Recently, SCNet.AI (www.scnet.ai) headquartered in Hong Kong has officially launched as a global AI&HPC computing service platform. With an ...
The BIOSECURE Act has moved from legislative possibility to operational reality. Enacted as part of the Fiscal Year 2026 National ...
As instruments grow faster, leaders say clinical impact will depend on trust, standards, data, and assays built for real ...
Illumina dominates genomics sequencing with recurring growth, NovaSeq X catalysts, and improving margins/FCF. Click to know ...
SCNet.AI has advanced its AI for Science platform, combining artificial intelligence and high-performance computing to make scientific research agents more accessible for accelerating discovery and ...
AI can identify individual wolves by their howls, giving conservationists a powerful new way to monitor packs without ...
13don MSN
Patents in the age of DeepTech
This article is authored by Aayush Sharma, partner designate, Patents and Designs, S&A Law Offices.
Vietnam Investment Review on MSN
Insilico Medicine issues positive profit alert for H1 2026
CAMBRIDGE, Mass., July 9, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico" or the "Company", HKEX: 3696), a generative artificial intelligence (AI)-driven clinical-stage biotech company, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results